Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use
Adicciones. 2021 Jun 14;0(0):1569. doi: 10.20882/adicciones.1569. Online ahead of print.ABSTRACTSubstantial evidence has confirmed the high comorbidity between Attention-Deficit/Hyperactivity Disorder (ADHD) and a substance use disorder (SUD). This review synthesizes the pharmacological and psychosocial interventions conducted in ADHD and SUDs, and provides clinical recommendations using the GRADE approach. Our results suggest: 1) In patients with ADHD and alcohol use, atomoxetine is recommended to reduce ADHD symptoms (weak recommendation) and alcohol craving (weak recommendation). 2) In patients with ADHD and cannabis us...
Source: Adicciones - June 25, 2021 Category: Addiction Authors: Ruth Cunill Xavier Castells Ana Gonz ález-Pinto Manuel Arrojo Miquel Bernardo Pilar Alejandra S áiz Gerardo Florez Marta Torrens Judit Tirado-Mu ñoz Francia Fonseca Bel én Arranz Marina Garriga Jose Manuel Goikolea I ñaki Zorrilla Elisardo Beco ña A Source Type: research
Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use
Adicciones. 2021 Jun 14;0(0):1569. doi: 10.20882/adicciones.1569. Online ahead of print.ABSTRACTSubstantial evidence has confirmed the high comorbidity between Attention-Deficit/Hyperactivity Disorder (ADHD) and a substance use disorder (SUD). This review synthesizes the pharmacological and psychosocial interventions conducted in ADHD and SUDs, and provides clinical recommendations using the GRADE approach. Our results suggest: 1) In patients with ADHD and alcohol use, atomoxetine is recommended to reduce ADHD symptoms (weak recommendation) and alcohol craving (weak recommendation). 2) In patients with ADHD and cannabis us...
Source: Adicciones - June 25, 2021 Category: Addiction Authors: Ruth Cunill Xavier Castells Ana Gonz ález-Pinto Manuel Arrojo Miquel Bernardo Pilar Alejandra S áiz Gerardo Florez Marta Torrens Judit Tirado-Mu ñoz Francia Fonseca Bel én Arranz Marina Garriga Jose Manuel Goikolea I ñaki Zorrilla Elisardo Beco ña A Source Type: research
Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use
Adicciones. 2021 Jun 14;0(0):1569. doi: 10.20882/adicciones.1569. Online ahead of print.ABSTRACTSubstantial evidence has confirmed the high comorbidity between Attention-Deficit/Hyperactivity Disorder (ADHD) and a substance use disorder (SUD). This review synthesizes the pharmacological and psychosocial interventions conducted in ADHD and SUDs, and provides clinical recommendations using the GRADE approach. Our results suggest: 1) In patients with ADHD and alcohol use, atomoxetine is recommended to reduce ADHD symptoms (weak recommendation) and alcohol craving (weak recommendation). 2) In patients with ADHD and cannabis us...
Source: Adicciones - June 25, 2021 Category: Addiction Authors: Ruth Cunill Xavier Castells Ana Gonz ález-Pinto Manuel Arrojo Miquel Bernardo Pilar Alejandra S áiz Gerardo Florez Marta Torrens Judit Tirado-Mu ñoz Francia Fonseca Bel én Arranz Marina Garriga Jose Manuel Goikolea I ñaki Zorrilla Elisardo Beco ña A Source Type: research
Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use
Adicciones. 2021 Jun 14;0(0):1569. doi: 10.20882/adicciones.1569. Online ahead of print.ABSTRACTSubstantial evidence has confirmed the high comorbidity between Attention-Deficit/Hyperactivity Disorder (ADHD) and a substance use disorder (SUD). This review synthesizes the pharmacological and psychosocial interventions conducted in ADHD and SUDs, and provides clinical recommendations using the GRADE approach. Our results suggest: 1) In patients with ADHD and alcohol use, atomoxetine is recommended to reduce ADHD symptoms (weak recommendation) and alcohol craving (weak recommendation). 2) In patients with ADHD and cannabis us...
Source: Adicciones - June 25, 2021 Category: Addiction Authors: Ruth Cunill Xavier Castells Ana Gonz ález-Pinto Manuel Arrojo Miquel Bernardo Pilar Alejandra S áiz Gerardo Florez Marta Torrens Judit Tirado-Mu ñoz Francia Fonseca Bel én Arranz Marina Garriga Jose Manuel Goikolea I ñaki Zorrilla Elisardo Beco ña A Source Type: research
Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use
Adicciones. 2021 Jun 14;0(0):1569. doi: 10.20882/adicciones.1569. Online ahead of print.ABSTRACTSubstantial evidence has confirmed the high comorbidity between Attention-Deficit/Hyperactivity Disorder (ADHD) and a substance use disorder (SUD). This review synthesizes the pharmacological and psychosocial interventions conducted in ADHD and SUDs, and provides clinical recommendations using the GRADE approach. Our results suggest: 1) In patients with ADHD and alcohol use, atomoxetine is recommended to reduce ADHD symptoms (weak recommendation) and alcohol craving (weak recommendation). 2) In patients with ADHD and cannabis us...
Source: Adicciones - June 25, 2021 Category: Addiction Authors: Ruth Cunill Xavier Castells Ana Gonz ález-Pinto Manuel Arrojo Miquel Bernardo Pilar Alejandra S áiz Gerardo Florez Marta Torrens Judit Tirado-Mu ñoz Francia Fonseca Bel én Arranz Marina Garriga Jose Manuel Goikolea I ñaki Zorrilla Elisardo Beco ña A Source Type: research
